These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Teriflunomide for multiple sclerosis. He D; Xu Z; Dong S; Zhang H; Zhou H; Wang L; Zhang S Cochrane Database Syst Rev; 2012 Dec; 12():CD009882. PubMed ID: 23235682 [TBL] [Abstract][Full Text] [Related]
8. Treatment with disease-modifying drugs for people with a first clinical attack suggestive of multiple sclerosis. Filippini G; Del Giovane C; Clerico M; Beiki O; Mattoscio M; Piazza F; Fredrikson S; Tramacere I; Scalfari A; Salanti G Cochrane Database Syst Rev; 2017 Apr; 4(4):CD012200. PubMed ID: 28440858 [TBL] [Abstract][Full Text] [Related]
9. A meta-analysis of the efficacy and tolerability of interferon-β in multiple sclerosis, overall and by drug and disease type. Nikfar S; Rahimi R; Abdollahi M Clin Ther; 2010 Oct; 32(11):1871-88. PubMed ID: 21095482 [TBL] [Abstract][Full Text] [Related]
10. Laquinimod for multiple sclerosis. He D; Han K; Gao X; Dong S; Chu L; Feng Z; Wu S Cochrane Database Syst Rev; 2013 Aug; (8):CD010475. PubMed ID: 23922214 [TBL] [Abstract][Full Text] [Related]
11. Amantadine for fatigue in multiple sclerosis. Taus C; Giuliani G; Pucci E; D'Amico R; Solari A Cochrane Database Syst Rev; 2003; (2):CD002818. PubMed ID: 12804439 [TBL] [Abstract][Full Text] [Related]
12. Low-fat, plant-based diet in multiple sclerosis: A randomized controlled trial. Yadav V; Marracci G; Kim E; Spain R; Cameron M; Overs S; Riddehough A; Li DK; McDougall J; Lovera J; Murchison C; Bourdette D Mult Scler Relat Disord; 2016 Sep; 9():80-90. PubMed ID: 27645350 [TBL] [Abstract][Full Text] [Related]
13. Mitoxantrone: a review of its use in multiple sclerosis. Scott LJ; Figgitt DP CNS Drugs; 2004; 18(6):379-96. PubMed ID: 15089110 [TBL] [Abstract][Full Text] [Related]
14. Non pharmacological interventions for spasticity in multiple sclerosis. Amatya B; Khan F; La Mantia L; Demetrios M; Wade DT Cochrane Database Syst Rev; 2013 Feb; (2):CD009974. PubMed ID: 23450612 [TBL] [Abstract][Full Text] [Related]
15. Information provision for people with multiple sclerosis. Köpke S; Solari A; Khan F; Heesen C; Giordano A Cochrane Database Syst Rev; 2014 Apr; (4):CD008757. PubMed ID: 24752330 [TBL] [Abstract][Full Text] [Related]
16. A Risk-Benefit Assessment of Dementia Medications: Systematic Review of the Evidence. Buckley JS; Salpeter SR Drugs Aging; 2015 Jun; 32(6):453-67. PubMed ID: 25941104 [TBL] [Abstract][Full Text] [Related]
18. The effect of exercise training in adults with multiple sclerosis with severe mobility disability: A systematic review and future research directions. Edwards T; Pilutti LA Mult Scler Relat Disord; 2017 Aug; 16():31-39. PubMed ID: 28755682 [TBL] [Abstract][Full Text] [Related]